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Summary
SpyCEP is a Streptococcus pyogenes protease that
cleaves CXCL8/IL-8 and its activity is associated with
human invasive disease severity. We investigated the
role of SpyCEP in S. pyogenes necrotizing fasciitis
and respiratory tract infection in mice using isogenic
strains differing only in SpyCEP expression. SpyCEP
cleaved human CXCL1, 2, 6 and 8 plus murine CXCL1
and 2 at a structurally conserved site. Mice were
infected in thigh muscle with a strain of S. pyogenes
that expresses a high level of SpyCEP, or with an
isogenic non-SpyCEP expressing strain. SpyCEP
expression by S. pyogenes hindered bacterial clear-
ance from muscle, and enhanced bacterial spread,
associated with cleavage of murine chemoattractant
CXCL1. Mice were then infected with Lactococcus
lactis strains that differed only in SpyCEP expression.
In contrast to the parent L. lactis strain (lacks
SpyCEP), which was avirulent when administered
intramuscularly, infection with a strain that expressed
SpyCEP heterologously led to dramatic systemic
illness within 24 h, failure to clear bacteria from
muscle and marked dissemination to other organs. In
the upper airways, SpyCEP expression was required
for survival of L. lactis but not S. pyogenes. However,
dissemination of S. pyogenes to the lung was
SpyCEP-dependent and was associated with evi-
dence of chemokine cleavage. Taken together, the
studies provide clear evidence that SpyCEP is neces-
sary and sufficient for systemic bacterial dissemina-
tion from a soft tissue focus in this model and also
underlies dissemination in the respiratory tract.
Introduction
Streptococcus pyogenes causes a range of invasive
infections including necrotizing fasciitis and myonecrosis.
Despite an attendant mortality as high as 50% (Stevens,
1995), the pathogenesis of S. pyogenes necrotizing fas-
ciitis is not completely understood. Many of the systemic
features of profound septic shock that commonly accom-
pany necrotizing fasciitis may stem from bacterial release
of exotoxins, including superantigens (Cunningham,
2000). The ability of S. pyogenes to spread rapidly at the
site of infection and to disseminate systemically indicates
the pathogen possesses robust mechanisms to resist the
human innate immune response.
Streptococcus pyogenes co-ordinates an array of viru-
lence factors to combat host opsonophagocytosis (Nizet,
2007). The streptococcal interleukin-8 (CXCL8/IL-8) inac-
tivating cell envelope protease, SpyCEP/cepA (Edwards
et al., 2005) [genomic annotation prtS, also known as
scpC (Ferretti et al., 2001; Hidalgo-Grass et al., 2006)], is
markedly upregulated in S. pyogenes strains during the
transition to invasive infection (Sumby et al., 2006; 2008;
Turner et al., 2009a). Coupled with clinical observations
that correlate SpyCEP production to disease severity
(Turner et al., 2009a), the published data suggest a
central role for SpyCEP in invasive infection.
SpyCEP cleaves ELR motif-positive CXC chemokines
such as CXCL8/IL-8, CXCL1/Gro-a and CXCL6/GCP-2,
as well as murine CXCL1/KC and CXCL2/MIP2 (Edwards
et al., 2005; Hidalgo-Grass et al., 2006; Sumby et al.,
2008; Fritzer et al., 2009). These chemokines are known
to signal via CXCR1 and CXCR2 receptors on phago-
cytes to activate and recruit such cells to the site of
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© 2010 Blackwell Publishing Ltdinfection. SpyCEP cleaves CXCL8/IL-8 within its
C-terminal a-helix, resulting in diminished function
(Edwards et al., 2005); other than murine CXCL2/MIP-2,
the precise cleavage sites within other chemokines have,
to date, not been deﬁned.
A number of investigators have sought to ascribe a role
for SpyCEP in soft tissue infection by assessment of
lesion size, yet the ﬁndings have been inconsistent, and
careful analysis of key parameters, such as bacterial load,
clearance and systemic spread, has yet to be performed
(Hidalgo-Grass et al., 2006; Sjolinder et al., 2008; Sumby
et al., 2008; Zinkernagel et al., 2008). In this study we set
out to explore the speciﬁc role of SpyCEP in necrotizing
soft tissue infection, with a critical focus on bacterial clear-
ance and bacterial dissemination. We couple loss-of-
function analysis, via an isogenic SpyCEP-deﬁcient
mutant created in a strain of S. pyogenes derived from a
patient with necrotizing fasciitis, with gain-of-function
analysis, through heterologous expression of SpyCEP in
Lactococcus lactis. The data unequivocally demonstrate
that SpyCEP expression impedes bacterial clearance and
augments dissemination of bacteria, both to the regional
lymph node, and into the systemic circulation. Infection
with SpyCEP-expressing L. lactis reproduced many of the
salient features of severe necrotizing S. pyogenes
infection. Failure of neutrophil-mediated bacterial clear-
ance orchestrated by the single virulence factor SpyCEP
may be a pivotal determinant of tissue necrosis and lethal-
ity observed in severe S. pyogenes infection.
Results
SpyCEP cleaves CXCL1, CXCL2, CXCL6 and CXCL8
at a structurally conserved site
The susceptibility of a wide panel of human CXC chemok-
ines (CXCL1-CXCL12) to cleavage by SpyCEP was sys-
tematically investigated by SDS PAGE analysis. Four ELR
motif-containing human chemokines (CXCL1/Gro-a,
CXCL2/Gro-b, CXCL6/GCP-2, and CXCL8/IL-8) were
cleaved, all of which are known to act as ligands for
CXCR1 and CXCR2 (Fig. 1A). Other human CXC
chemokines were not cleaved (not shown). The cleavage
sites of CXCL8/IL-8 and murine CXCL2/MIP-2 were pre-
viously reported (Edwards et al., 2005). Mass spectrom-
etry analysis of cleaved and uncleaved human CXCL1/
Gro-a and CXCL2/Gro-b identiﬁed the SpyCEP cleavage
site to be between lysine residues K60 and K61 in both
chemokines, while analysis demonstrated the murine
CXCL1/KC molecule to be cleaved between Q65 and K66.
(Fig. 1B and C). In each case, cleavage occurred just
distal from the known or predicted start of the C-terminal
a-helix regardless of differences in amino acid residues
ﬂanking the cleavage site, suggesting that SpyCEP
cleaves the ELR motif CXC chemokines at a site that is
structurally conserved. The cleavage site of CXCL6/
GCP-2, which demonstrated only partial cleavage, could
not be deﬁned with certainty.
SpyCEP resists bacterial clearance and contributes to
S. pyogenes dissemination from soft tissue
We sought to determine the role of SpyCEP in invasive
infection using a clinical necrotizing fasciitis strain that
expresses SpyCEP at high level, as high level expression
of SpyCEP characterizes many invasive infections
(Turner et al., 2009a). In comparison to the parent S.
pyogenes strain (H292), the mutant cepA strain (H575)
produced a C-terminally truncated SpyCEP protein that
lacked one of the three residues necessary for serine
protease activity (Fig. 2A). Functional disruption of the
cepA locus was conﬁrmed by Southern blotting (Fig. S1A)
and CXCL8/IL-8 cleavage studies, which demonstrated
unequivocally that SpyCEP was responsible for CXCL8/
IL-8 cleavage (Fig. S1B). Strains H575 and H292 were
phenotypically similar and demonstrated no differences in
growth in broth or whole blood. Proteomic analysis of
secreted proteins demonstrated no difference between
H575 and H292 except for the production of a truncated
SpyCEP protein by H575, and production of the cysteine
protease SpeB was unchanged between the two strains.
To determine whether the insertion mutation led to polar
effects on surrounding genes, real-time PCR analysis was
conducted on the two genes immediately upstream of
cepA (exoA and lctO) and four genes immediately down-
stream of cepA (hypothetical permease, metS, nrdF,
nrdE). There were no differences in expression of these
genes in H575 compared with H292 during either expo-
nential or early stationary growth phase, suggesting that
the mutation of cepA did not result in disruption of the
surrounding genes (data not shown).
Murine intramuscular infection with S. pyogenes parent
andcepAmutantstrainsdemonstratedthathostclearance
of S. pyogenes from muscle at 24 h after infection onset
was impeded by SpyCEP expression (Fig. 2B), providing
the ﬁrst evidence that SpyCEP interferes with bacterial
clearance at the site of deep soft tissue infection. Bacterial
dissemination to the regional draining lymph node was
augmented 100- to 1000-fold by SpyCEP; indeed, in the
absence of SpyCEP, mice demonstrated little or no dis-
semination of S. pyogenes (Fig. 2C). Dissemination to
other organs or blood was not observed at the bacterial
inocula used, so the inoculum was increased to provide a
10-fold higher dose (109 colony-forming units, cfu). Mice
infected with wild-type S. pyogenes had a signiﬁcantly
greater bacterial load in blood (median, 1 ¥ 103 cfu ml-1;
range, 3 ¥ 102 to 1 ¥ 105 cfu ml-1) than mice infected with
the cepA mutant strain H575 (median, undetectable;
range, undetectable to 3 ¥ 102 cfu ml-1; P < 0.01).
1388 P. Kurupati etal. 
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 76, 1387–1397Cleavage of murine CXCL1/KC locally and systemically
by SpyCEP during S. pyogenes infection
Chemokine levels normally reﬂect bacterial load during S.
pyogenes infection. Despite an increased bacterial
burden, infection with wild-type S. pyogenes actually
reduced CXCL1/KC levels in muscle tissue (median,
37 ng ml-1; range, 23–49 ng ml-1) compared with mice
infected with the cepA mutant (median, 78 ng ml-1; range,
37–93 ng ml-1; P < 0.001), consistent with chemokine
inactivation by SpyCEP (Fig. 3), since the enzyme-linked
immunosorbant assay (ELISA) recognizes only full-length
rather than cleaved CXCL1/KC. Notably, inactivation of
CXCL1/KC by SpyCEP extended beyond the site of infec-
tion, affecting serum CXCL1/KC levels in mice infected
with wild-type S. pyogenes (median, 57 ng ml-1; range,
Fig. 1. SpyCEP cleaves human CXCL1, 2, 6 and 8 and murine CXCL1/2 after the ﬁrst four amino acids of the C-terminal a-helix.
A. Colloidal Coomassie blue stained SDS-PAGE gels showing human chemokines cleaved by SpyCEP. Chemokines were co-incubated either
alone (left lane); with supernatant containing SpyCEP, H292 (+SpyCEP, middle lane); or supernatant without SpyCEP, H575 (-SpyCEP,
right lane).
B. Mass spectroscopy analysis of uncleaved and cleaved chemokines using electrospray ionization generated a series of multiply charged
ions (indicated as m/z; mass-to-charge ratio) from which the average molecular mass (m) of each was deduced.
C. Site of SpyCEP-mediated cleavage of various chemokines determined in this study and previously for CXCL8/IL-8 and CXCL2/MIP-2
(Edwards et al., 2005): arrowhead. The position of the a-helix in this region is indicated by a grey shaded box.
SpyCEP and S. pyogenes dissemination 1389
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 76, 1387–139743–84 ng ml-1) compared with those infected with the
cepA mutant (median, 75 ng ml-1; range, 48–99 ng ml-1;
P < 0.05) (Fig. 3).
Expression of SpyCEP in L. lactis confers ability to
resist bacterial clearance from soft tissue and
disseminate systemically
Lactococcus lactis is a non-pathogenic bacterium that
does not produce SpyCEP, nor cleave CXCL8/IL-8 and
related chemokines. However, L. lactis strain H487 was
engineered to heterologously express biologically active
SpyCEP (Zinkernagel et al., 2008). Western blotting con-
ﬁrmed that SpyCEP was produced both at the cell wall
and also as a soluble exoprotein, released into culture
supernatant, emulating SpyCEP production by S. pyo-
genes (Fig. 4A). The concentration of SpyCEP released
by H487 into the culture supernatant was measured by
ELISA and was found to be 12 ng ml-1 compared with
69 ng ml-1 made by H292. Being avirulent, L. lactis is
normally rapidly cleared by the murine immune system
(Que et al., 2005; Maisey et al., 2008); indeed, in pilot
experiments using a high inoculum of 1011 cfu, L. lactis
could not be detected in muscle 24 h after intramuscular
administration. In contrast, following intramuscular infec-
tion with L. lactis, heterologous expression of SpyCEP by
L. lactis conferred the ability to resist clearance at the site
of infection (median, 5 ¥ 107 cfu mg-1; range, 8 ¥ 106 to
7 ¥ 107 cfu mg-1) compared with the parent lactococcal
strain (median, undetectable; range, undetectable to
Fig. 2. SpyCEP inﬂuences bacterial clearance in soft tissue and systemic spread of S. pyogenes.
A. SpyCEP production by S. pyogenes parent strain H292 and mutant cepA strain H575. Western blots were performed on culture
supernatants (left panel) and cell wall preparations (right panel). Wild-type SpyCEP was detected as an approximate 160 kDa band in both the
supernatant and the cell wall preparation from strain H292. Strain H575 produced an inactive truncated N-terminal SpyCEP fragment of
approximately 40 kDa in the culture supernatant, but not the cell wall due to lack of a cell wall anchor motif.
B. Expression of SpyCEP by strain H292 enhanced S. pyogenes survival at the site of infection following intramuscular infection of CD1
female mice compared with strain H575 (P = 0.0019; inoculum 2 ¥ 10
8 cfu).
C. Expression of SpyCEP also enhanced spread of S. pyogenes to the regional lymph node (P = 0.0001). n = 10 mice per group in each
experiment, representative of two experiments. ND, not detected; cfu, colony-forming units; horizontal line, median.
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expression of SpyCEP also permitted bacterial dissemi-
nation to regional lymph node, liver and spleen
(Fig. 4C–E). In separate experiments conducted to detect
bacteremia, all mice infected with SpyCEP-expressing L.
lactis intramuscularly were bacteremic at 24 h (median
280 cfu ml-1, range 192 to 1 ¥ 107 cfu ml-1), whereas bac-
teremia was not detected in any mouse infected with the
parent L. lactis strain.
The chemokine CXCL1/KC could not be detected at all
in mice infected with the parent L. lactis strain, consistent
with their complete recovery and clearance of bacteria,
thus it was not possible to compare chemokine levels
between groups.
Heterologous expression of SpyCEP in L. lactis is
sufficient to cause soft tissue necrosis, systemic
disease and death
Although the primary aim of the study was to obtain quan-
titative bacteriological data, 10/10 mice infected with
SpyCEP-expressing L. lactis reached the protocol-
deﬁned survival end-point for infection by 24 h (unrespon-
sive to stimuli, loss of spontaneous movement), whereas
all mice infected with the parent L. lactis strain showed no
ill effects. Furthermore, mice infected with SpyCEP-
expressing L. lactis lost more weight (median 93% of
original weight, range 88.8–98.9%) during the 24 h
experiment than those infected with the parent L. lactis
strain (median 100.6% of original weight, range
97.7–103%, P < 0.0001). Taken together, the above data
demonstrate that SpyCEP conferred a lethal phenotype to
L. lactis that was manifest within 24 h of infection.
Blood samples taken from mice 7 h after L. lactis infec-
tion demonstrated that mice infected with SpyCEP
expressing strains were already bacteremic (median
448 cfu ml-1, range 28–764 cfu ml-1), whereas bacteremia
was not seen in mice infected with the parent L. lactis
strain. To investigate early pathogenic events, histopathol-
ogy specimens from the thigh were obtained 3 and 6 h
following infection with L. lactis. Studies demonstrated
that visible differences in bacterial load between experi-
mental groups of mice evolved between 3 and 6 h after
administration of bacterial inocula (Fig. 5). At 6 h, conﬂu-
ent areas of Gram-positive bacterial growth were
observed in mice infected with the SpyCEP-expressing L.
lactis in contrast to mice infected with the wild-type L.
lactis, where bacteria could not be detected. Despite
expression of SpyCEP, inﬂammatory cells were visible at
the site of infection in mice infected with the SpyCEP-
expressing L. lactis strain. A visible necrotic inﬂammatory
inﬁltrate was observed in tissues of mice exposed to
SpyCEP-expressing L. lactis around areas of bacterial
conﬂuent growth, despite the fact that L. lactis itself does
not express virulence factors known to degrade mamma-
lian tissues or elicit neutrophil necrosis. The unopposed
spread of bacteria along tissue planes was very similar to
that seen in aggressive S. pyogenes necrotizing fasciitis
(Sriskandan et al., 1999).
SpyCEP enhances S. pyogenes dissemination to lower
respiratory tract from nasopharynx
Following intranasal infection with S. pyogenes or with L.
lactis, S. pyogenes could be recovered from the nose and
nasal associated lymphoid tissues (NALT) 24 h after
administration (Fig. 6A and B), in contrast to L. lactis,
which was cleared by 24 h (Fig. 6D and E). Although
SpyCEP expression did not measurably contribute to sur-
vival of S. pyogenes in the nasopharynx, heterologous
expression of SpyCEP was sufficient to allow survival in
the nasopharynx by L. lactis (Fig. 6A, B, D and E). Intrigu-
ingly, however, SpyCEP expression did enhance S. pyo-
genes dissemination to the lung from the nasopharynx
although it was not, alone, sufficient to allow L. lactis to
survive in the lung (Fig. 6C and F). Mice infected with the
parent S. pyogenes strain demonstrated higher bacterial
counts in the lung (median, 2 ¥ 103 cfu mg-1; range, unde-
tectable to 1 ¥ 104 cfu mg-1), than mice infected with the
non-SpyCEP producing mutant (median, undetectable;
range, undetectable to 2 ¥ 103 cfu mg-1).
SpyCEP leads to local and systemic chemokine
cleavage during S. pyogenes lower respiratory
tract infection
In mice infected with S. pyogenes, there was an inverse
relationship between bacterial load and CXCL1/KC levels
during respiratory tract infection. Despite higher bacterial
Fig. 3. Levels of KC (murine CXCL1) in mouse serum (left axis)
and mouse whole thigh homogenate (right axis) 24 h after infection
with S. pyogenes. KC was measured by ELISA. Infection with
parent strain H292 reduced chemokine levels compared with those
mice infected with mutant strain H575 in both serum and thigh
muscle. n = 10 mice per group.
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A. Heterologous expression of SpyCEP by L. lactis strain H487 and parental control L. lactis strain H486. Western blots for SpyCEP were
performed on culture supernatants (left panel) and cell wall preparations (right panel). H487 produced SpyCEP in both supernatant and cell
wall. Lower molecular weight bands represent autocatalytic cleavage of SpyCEP.
B. Bacterial quantiﬁcation in muscle tissue demonstrating heavy growth in mice infected with SpyCEP-expressing L. lactis strain H487
compared with control strain H486 (P = 0.0001).
C. Bacterial dissemination of L. lactis to regional lymph node. Quantiﬁcation of bacteria in each inguinal lymph node shows greater bacterial
spread to node in mice infected with H487 compared with H486 (P = 0.0015).
D. Bacterial quantiﬁcation in liver. SpyCEP was also essential for systemic spread of L. lactis to liver with greater bacterial burden in liver of
mice infected with H487 compared with H486 (P = 0.012).
E. Bacterial quantiﬁcation in spleen with greater bacterial burden in spleen of mice infected with H487 compared with H486 (P = 0.0003).
n = 10 per group representative of two experiments. ND, not detected; cfu, colony-forming units; horizontal line, median.
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demonstrated lower levels of CXCL1/KC in both lung
tissue and serum (lung median, 32 ng ml-1; range,
10–40 ng ml-1; serum median, 4.7 ng ml-1; range,
1–6 ng ml-1) than mice infected with the non-SpyCEP pro-
ducing mutant (lung median, 86 ng ml-1; range,
50–120 ng ml-1, P < 0.0001; serum median, 9 ng ml-1;
range, 5–23 ng ml-1, P < 0.01) (Fig. 7). This is consistent
with chemokine cleavage occurring both in the lung and
systemically as a speciﬁc effect of SpyCEP.
Discussion
SpyCEP is a recently described serine protease of S.
pyogenes that cleaves the major human chemokine
CXCL8/IL-8 through the origin of the C-terminal a-helix
(Edwards et al., 2005). Clinical and transcriptomic studies
suggest that SpyCEP may play a central role in invasive
S. pyogenes infection (Sumby et al., 2006; Sumby et al.,
2008; Turner et al., 2009a). In this study, we sought to
deﬁne the role played by SpyCEP in both soft tissue and
lower respiratory tract invasive infection, using both site-
directed mutagenesis of S. pyogenes and heterologous
expression in L. lactis.
We demonstrate the cleavage sites of each SpyCEP-
cleaved chemokine to be restricted to a single site within
the ﬁrst four bases of the predicted C-terminal a-helix.
Taken together with the previously reported cleavage
sites of CXCL8/IL-8 (Q59–R60) and murine CXCL2/MIP-2
(Q60–K61) (Edwards et al., 2005), the sites for cleavage by
SpyCEP appear to be highly speciﬁc and dictated by
location within the tertiary structure of the protein rather
than by a simple sequence motif.
Phenotypic changes in S. pyogenes can arise during
invasive soft tissue infection, and have been linked in
some cases to genotypic changes in the two component
virulence regulator, covR/S (Engleberg et al., 2001;
Sumby et al., 2006; Walker et al., 2007). Although covR/S
regulates many genes necessary for resistance to
opsonophagocytosis, the invasive phenotype is charac-
terized, in particular, by increased transcription of the
gene encoding SpyCEP, suggesting a central role for
SpyCEP in invasive infection (Sumby et al., 2006; 2008;
Turner et al., 2009a). In the current study we determined
Fig. 5. Tissue sections from thigh muscle of L. lactis-infected mice obtained at 3 and 6 h after onset of infection suggest that SpyCEP is
sufficient to reproduce some features of invasive necrotizing infection. Gram stained muscle sections from L. lactis-infected mice at 3 and 6 h
after infection (left and central panels). Upper panels, mice infected with control L. lactis H486 (empty plasmid); Lower panels, mice infected
with L. lactis strain expressing SpyCEP, H487. Right hand panels, haematoxylin and eosin-stained tissues at 6 h. L, lactococci; N, neutrophils;
nN, necrotic neutrophil. Representative of three mice at each time point, magniﬁcation ¥200.
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necrotizing fasciitis S. pyogenes strain, H292, that
expresses SpyCEP at high level (Turner et al., 2009a). In
this strain, SpyCEP was necessary for systemic dissemi-
nation, exerting a marked effect on spread to lymph node
from soft tissue. We were unable to complement the
isogenic mutant strain H575 but studies suggested that
the mutation had not resulted in a polar or non-speciﬁc
effect on phenotype. Three other recent studies have
demonstrated that SpyCEP contributes to increased
lesion size in streptococcal dermal necrosis (Hidalgo-
Grass et al., 2006; Sjolinder et al., 2008; Zinkernagel
et al., 2008), although a similar mutation in a different
strain background did not produce this pattern of virulence
attenuation (Sumby et al., 2008). Differences between
mouse strains, bacterial strains, baseline SpyCEP
expression, or covR/S mutations arising during infection,
may account for the varied ﬁndings.
In the upper respiratory tract, SpyCEP contributed to
nasopharyngeal S. pyogenes survival but was not
essential. S. pyogenes expresses a number of virulence
factors that may allow infection or colonization of the
nasopharynx, thereby compensating for SpyCEP. In con-
trast, SpyCEP expression played a greater role in the
spread of S. pyogenes from nasopharynx to lung. This is
relevant to the pathogenesis of S. pyogenes lower respi-
ratory tract infection, a common clinical focus in addition
to skin and soft tissue disease. Given that regulatory
Fig. 6. SpyCEP enhances S. pyogenes dissemination to lung from the upper respiratory tract. S. pyogenes studies are shown in (A), (B) and
(C) (10 mice per group). Following intranasal infection, S. pyogenes survival in the nasal tissues (A) and NALT (B) was unaffected by
disruption of SpyCEP. However, S. pyogenes dissemination into the lower respiratory tract (C) was enhanced by SpyCEP expression
(P = 0.02). Lactococcal studies are shown in (D), (E) and (F) (8 mice per group). SpyCEP expression by L. lactis was sufficient to allow
survival in the nasal tissues (P = 0.001) (D) and also enhanced survival in NALT (P = 0.046) (E). SpyCEP did not signiﬁcantly affect survival of
L. lactis in the lower respiratory tract (F). ND, not detected; cfu, colony-forming units; horizontal line, median. Data from one experiment for
each strain.
Fig. 7. Levels of KC (murine CXCL1) in mouse lung homogenate
(left side axis) and mouse serum (right side axis) 24 h after
infection with S. pyogenes. Infection with parent strain H292
reduced chemokine levels compared with those mice infected with
mutant strain H575 in both lung and serum. n = 10 mice per group.
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to occur during the transition from pharyngeal to invasive
infection (Sumby et al., 2006), the ﬁndings may also be
relevant to the systemic dissemination of S. pyogenes
from the upper respiratory tract.
Heterologous expression of SpyCEP by the otherwise
avirulent L. lactis led to a striking illness associated with a
failure to clear bacteria from soft tissue and dissemination
of bacteria to lymph node, distant organs and blood.
ELISA showed that SpyCEP production by the trans-
formed L. lactis was not greater than the wild-type S.
pyogenes strain, thus it is unlikely that the results
obtained arose due to excessive production of SpyCEP
compared with S. pyogenes (Figs 2A and 3A).
To further understand the reasons for uncontrolled
sepsis in L. lactis-infected mice, histopathological exami-
nation of infected muscle was undertaken, conﬁrming that
the effects of SpyCEP are manifest as early as 3–6 h after
infection onset. The features of conﬂuent Gram-positive
bacteria spreading along tissue planes associated with
necrotic inﬂammation were similar to those observed in
necrotizing S. pyogenes infection. The ﬁndings raise the
possibility that the features of necrotizing soft tissue infec-
tion arise directly from host cell exposure to SpyCEP or
through exposure to an inadequately cleared necrotic
inﬂammatory inﬁltrate. Our preliminary studies do not
support a role for SpyCEP in enzymatic cleavage of mam-
malian proteins other than chemokines (P.K., C.T., S.S.,
unpublished). Histopathology studies demonstrated that
neutrophil recruitment was not completely inhibited in
mice infected with SpyCEP-expressing L. lactis. We con-
sidered the possibility that partial loss of the SpyCEP
expression plasmid may occur during infection. Experi-
ments demonstrated that erythromycin resistance was
maintained in both isogenic L. lactis strains at all time
points studied, thus plasmid loss was unlikely to affect
chemokine cleavage. We conclude that some neutrophil
recruitment will occur either independent of CXC chemok-
ines or through residual chemokine activity. Despite the
presence of inﬂammatory cells, expression of SpyCEP by
L. lactis successfully prevented bacterial clearance. This
is consistent with the hypothesis that SpyCEP confers
additional harm to neutrophil function and may prevent
neutrophil killing of bacteria. Inactivation of CXCR1 and 2
ligands will have pleiotropic effects on neutrophil function
and may additionally inﬂuence neutrophil death pathways
(Guichard et al., 2005).
SpyCEP is a member of a larger family of cell envelope
proteaseshomologoustolactococcalenzymesthatcleave
casein (Siezen, 1999). Among pathogenic streptococci,
these genes have diversiﬁed to yield a family of strepto-
coccal C5a peptidases (scpA and B), which do not cleave
chemokines (Hill et al., 1988; Cleary et al., 1992), and a
separate family of CXC chemokine-cleaving cell envelope
proteinases(CEPs),whichdonotcleaveC5a(Harriset al.,
2003; Zinkernagel et al., 2008; Bryan and Shelver, 2009;
Turner et al., 2009b). The pathogenic impact of this wider
family of chemokine cleaving enzymes in other hemolytic
streptococci remains to be fully explored.
SpyCEP impacts on neutrophil recruitment, phagocytic
function and longevity (Edwards et al., 2005; Sumby
et al., 2008; Zinkernagel et al., 2008); it may also have
effects on neutrophil clearance and the relative contribu-
tions of these different functions to pathogenesis are the
subject of further study. Active immunity against SpyCEP
halts dissemination of S. pyogenes during soft tissue
infection (Turner et al., 2009b), suggesting that SpyCEP
may be a suitable vaccine target for protection against
invasive S. pyogenes infection. Together with the current
data, it is evident that SpyCEP plays a central role in
bacterial dissemination during invasive S. pyogenes
infection, conferring a lethal phenotype that may contrib-
ute to the rapid clinical deterioration so often observed in
patients with invasive streptococcal infection.
Experimental procedures
Bacterial strains and construction of a SpyCEP mutant
Streptococcus pyogenes invasive isolate H292 (emm81) was
isolated from a patient with bacteremia and lethal necrotizing
fasciitis and was the parent strain used to create a DcepA
knock-out. L. lactis expressing SpyCEP (H487) and L. lactis
containing empty plasmid pDESTerm (H486) were reported
previously (Zinkernagel et al., 2008). S. pyogenes and L.
lactis were grown in Todd-Hewitt broth (Oxoid, Basingstoke,
UK) or on Todd-Hewitt agar or Columbia horse blood agar.
Escherichia coli strains were cultured in Luria–Bertani broth
(Oxoid). Antibiotics were used at the following concentra-
tions: erythromycin 1 mgm l
-1 (for S. pyogenes)o r5mgm l
-1
(for L. lactis), and kanamycin 50 mgm l
-1 for E. coli.
The SpyCEP gene, cepA, was disrupted by site-directed
mutagenesis in S. pyogenes strain H292 to generate strain
H575. Brieﬂy, a 246–974 bp region of the cepA coding
sequence was ampliﬁed using cepA-knock-out primers
cepAF (CGGAATTCAACCACAACGAGTGAACCAA) and
cepAR (CGGAATTCTGCATACCGTGTGACTCGTAT) from
strain H292 DNA and cloned into the EcoRI site of the
temperature-sensitive shuttle vector pGHostaph1 (Unnikrish-
nan et al., 2002). The plasmid, designated pGHost-cepA,
was extracted from E. coli and then used to transform S.
pyogenes strain H292 by electroporation. Transformants
were selected using erythromycin at 30°C and then moved to
37°C in liquid culture to obtain plasmid integration. Transfor-
mants were analysed by Southern and Western blot to
conﬁrm disruption of cepA. Isogenic isolates were compared
with regard to CXCL8/IL-8 cleaving activity, by sodium
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE). Isolates were also compared by SDS-PAGE analysis
of secreted proteins, and by expression of the cysteine pro-
tease, SpeB by western analysis using polyclonal antiSPEB
antibody (Toxin Technology, Sarasota, FL, USA).
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Southern analysis was performed on XmnI-cut genomic DNA
extracted from the parent strain H292 and transformant,
H575, using a 728 bp digoxygenin (DIG)-labelled cepA probe
(amplicon prepared using primers cepAF and cepAR). South-
ern blot of XmnI-cut genomic DNA demonstrated a change in
the cepA locus from 4.9 kb in H292 to 6.5 kb in H575 con-
ﬁrming pGHost-cepA integration (Fig. S1B).
Western blot analysis of culture supernatant and cell wall
fractions was performed as described previously (Turner
et al., 2009a). Brieﬂy, cell wall fraction was obtained after 3 h
incubation of cell pellets with 10 mM Tris-HCl, 30% raffinose,
1 0 0Um l
-1 mutanolysin, 1 mg ml
-1 lysozyme and Calbiochem
protease inhibitor III. Cell wall fractions were then collected in
the resulting supernatant. Proteins were separated using pre-
cast 10% Bis-Tris SDS-PAGE gels (Invitrogen, UK) and
immunoblotted with a rabbit polyclonal anti-SpyCEP serum
raised against a recombinant protein representing residues
35–587 of the pre-pro SpyCEP enzyme sequence (GenBank
DQ413032) (Turner et al., 2009b). Blots were developed
using the ECL system (GE Healthcare, UK).
Real-time PCR analysis
Primersweredesignedtoamplifya100–200 bpregionofeach
of the genes surrounding the cepA locus; exoribonuclese III
(exoA, exoAF: 5′-CATCACCAGCATTAGGCGTG-3′, exoAR:
5′-CTATGCTGGCACCATGTTCC-3′) and lactate oxidase
(lctO, lctO F: 5′-GGAAGTATCTACACCACTAGTTCC-3′, lctO
R: 5′-GCTTTGACACGATCCATAAT-3′) upstream and a hypo-
thetical permease (Permease F: 5′-GTCAGAACAGC
AACTGAAGG-3′, Permease R: 5′-AGCTGCTACCGT
AACATTGG-3′), methionyl-tRNA synthetase (metG/S, metS
F: 5′-GAAGACGGTCAGGTTATTGG-3′, metS R: 5′-AGTA
CGGCTAACAGCCAAATC-3′), ribonucleoside-diphosphate
reductase b-chain (nrdF, NrdF F: 5′-TTTACCTAT
CAGCACGTGG-3′, NrdR R: 5′-TGCATACAGTTCTCTC
AAGTAAGC-3′), and ribonucleoside-diphosphate reductase
a-chain (nrdE.2, NrdE F: 5′-CTGCTAGCCAATCCAGCCATC-
3′, NrdE R: 5′-CACAGGTTAGACATGACGATTC-3′) down-
stream. RNA was extracted from H292 and H575 at
exponential phase (A600 0.5) and early stationary phase (A600
0.7–0.8) and converted into cDNA as described previously
(Turner et al., 2009a). Real-time PCR was performed using
SYBR green as described previously (Turner et al., 2009a)
andnormalizedtothehousekeepinggenegyrA.Relativegene
expression and statistical analysis were performed using
REST analysis (Pfaffl et al., 2002).
SpyCEP enzyme-linked immunosorbant assay
Anti-SpyCEP antibodies were puriﬁed from rabbit polyclonal
anti-SpyCEP serum using CnBr-activated sepharose 4 fast
ﬂow (GE Healthcare). Puriﬁed antibody (2 mg ml
-1) was
labelled with biotin using EZ-link Sulfo-NHS Biotinylation kit
(Perbio, UK) according to the manufacturer’s instructions. A
96-well ELISAplate was coated with 0.4 mgm l
-1 of unlabelled
anti-SpyCEP antibody. Biotin labelled anti-SpyCEP antibody
at 20 mgm l
-1 was used to detect SpyCEP in cell-free culture
supernatant and the concentration of SpyCEP was calculated
against a standard curve based on recombinant SpyCEP
(Turner et al., 2009b). Samples were measured in duplicate
by ELISA and data from the mean of three cultures were
compared.
Analysis of SpyCEP-cleaved CXC chemokines by
SDS-PAGE and mass-spectrometry
Cell-free S. pyogenes culture supernatant was incubated at
37°C for ~18 h with 200 ng carrier-free human/mouse
chemokine (human CXCL1–CXCL12, mouse CXCL1/KC and
CXCL2/MIP-2). Proteins were separated by pre-cast 12%
Bis-Tris SDS-PAGE (Invitrogen) and stained with Colloidal
Comassie Blue staining kit (Invitrogen). Exact cleavage sites
were identiﬁed by mass spectrometry analysis as described
previously for CXCL8/IL-8 and CXCL2/MIP-2 (Edwards et al.,
2005), except that cleaved proteins in solution were injected
directly into an LTQ Linear IonTrap mass spectrometer
(Thermo).
Ethics statement
All animals were handled in strict accordance with good
animal practice as deﬁned by the UK Home Office, and all
animal work was approved by the local ethics committee.
Mouse infection models
CD1 female mice (6–8 weeks old) (Charles River, Margate,
UK) were infected with 10
8 cfu isogenic S. pyogenes or L.
lactis directly into thigh muscle and quantitative end-points
compared at 24 h. Mice were euthanized and blood was
taken by cardiac puncture. To evaluate bacterial clearance,
excised spleen, liver and infected thigh muscle from mice
were individually weighed, homogenized, diluted and plated
onto horse blood agar; and after overnight incubation at
37°C, cfu were noted. In some experiments using L. lactis,
mice were euthanized at 3 and 6 h for histopathology. Sur-
vival end-points were deﬁned by strict criteria relating to one
or more of: loss of spontaneous movement, loss of response
to stimuli, weight loss.
For intranasal infection mice were anesthetized with isof-
lurane and 10
8 cfu S. pyogenes or 10
9 cfu L. lactis were
administered as 10 ml per nostril.After 24 h of infection, whole
nasal tissue, NALT (homologue to human tonsil) and whole
lung tissue were excised and bacterial load was quantiﬁed as
above. Serum and infected tissue CXCL1/KC was measured
by ELISA(R&D systems) that only detects full-length CXCL1/
KC, not SpyCEP-cleaved CXCL1/KC. To maintain L. lactis
constructs in vivo, both groups of L. lactis-infected mice were
given three doses of 50 mgm l
-1 erythromycin intraperito-
neally; 4 h before infection then 6 h and 20 h post infection.
Statistical analysis
Data were analysed using GraphPad Prism 4.0 (GraphPad
software) and statistical signiﬁcance determined between
groups by applying the Mann–Whitney U-test. Values of
P < 0.05 were considered as signiﬁcant.
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